Soo Kyung Jeong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Soo Kyung Jeong has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Wol Soon Jo
Dongnam Institute of Radiological & Medical Sciences, Busan, Republic of Korea
2 shared publications Chang Geun Lee
Dongnam Institute of Radiological and Medical Sciences (DIRAMS), Busan, Republic of Korea
1 shared publication- Chang Geun Lee
Dongnam Institute of Radiological & Medical Sciences, Busan, Republic of Koreas
1 shared publication HyoJin Kim
Dongnam Institute of Radiological and Medical Sciences (DIRAMS), Busan, Republic of Korea
1 shared publicationJeong-Hwa Baek
Dongnam Institute of Radiological and Medical Sciences (DIRAMS), Busan, Republic of Korea
1 shared publicationJoong Sun Kim
College of Veterinary Medicine and BK21 Plus project team, Chonnam National University, Gwangju, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 27 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Automated system for establishing standard radiation dose–response curves and dose estimation for the Korean population
Biological dosimetry is crucial for estimating the doses from biological samples and guiding medical interventions for accidental radiation exposure. This study aimed to derive rapid and precise dose estimates using a dicentric chromosome assay. To address the challenges of manual scoring of dicentric chromosomes, we upgraded an automatic system aimed at enhancing the precision of dicentric chromosome detection while reducing the need for human intervention. We collected blood from 30 individuals aged 20–67 years to create 30 dose-response curves aiming to investigate the differences in responses among individuals. To validate dose-estimate accuracy within a 95% confidence interval, blinded samples were categorized into three groups according to the radiation dose as follows: ≥2, ≤ 1, and 0.1 Gy. When scoring dicentric chromosomes without human review and constructing a dose–response curve, individual differences were observed. For doses ≤ 1 Gy, the standard root formula was effective; conversely, for doses ≥ 2 Gy, the regression deep neural network proved to be more ac-curate. Our developed program allowed for the rapid analysis of a large volume of dicentric chromosome images.
- 27 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Open AccessAutomated system for establishing standard radiation dose–response curves and dose estimation for the Korean population
Biological dosimetry is crucial for estimating the doses from biological samples and guiding medical interventions for accidental radiation exposure. This study aimed to derive rapid and precise dose estimates using a dicentric chromosome assay. To address the challenges of manual scoring of dicentric chromosomes, we upgraded an automatic system aimed at enhancing the precision of dicentric chromosome detection while reducing the need for human intervention. We collected blood from 30 individuals aged 20–67 years to create 30 dose-response curves aiming to investigate the differences in responses among individuals. To validate dose-estimate accuracy within a 95% confidence interval, blinded samples were categorized into three groups according to the radiation dose as follows: ≥2, ≤ 1, and 0.1 Gy. When scoring dicentric chromosomes without human review and constructing a dose–response curve, individual differences were observed. For doses ≤ 1 Gy, the standard root formula was effective; conversely, for doses ≥ 2 Gy, the regression deep neural network proved to be more ac-curate. Our developed program allowed for the rapid analysis of a large volume of dicentric chromosome images.
- 23 March 2022
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 31 (4) , 433-441
Resveratrol analogue, HS-1793, inhibits inflammatory mediator release from macrophages by interfering with the TLR4 mediated NF-κB activation
Resveratrol is known to have anti-inflammatory properties. However, high-dose resveratrol is required for optimal anti-inflammatory effects. HS-1793 is a derivative designed to be metabolically stable and more effective than resveratrol. We tested whether HS-1793 also has anti-inflammatory activity. HS-1793 effectively inhibited the mRNA and protein expression of lipopolysaccharide (LPS)-induced inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in macrophages. Therefore, the production of nitric oxide (NO) and prostaglandin E2 (PGE2) was significantly attenuated. In addition, HS-1793 completely suppressed the production of inflammatory cytokines enhanced by LPS treatment along with a decrease in Toll-like receptor 4 (TLR4) expression. At the same time, the expression of myeloid differentiation factor 88 (MyD88), IL-1 receptor-associated kinase 1 (IRAK1), and TNF receptor-associated factor 6 (TRAF6) signaling molecules and the nuclear translocation of nuclear factor kappa B (NF-κB)/p65 were also downregulated. We conclusively suggest that HS-1793 also exhibits anti-inflammatory properties by effectively inhibiting TLR4-mediated NF-κB activation.
- 23 March 2022
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 31 (4) , 433-441
Resveratrol analogue, HS-1793, inhibits inflammatory mediator release from macrophages by interfering with the TLR4 mediated NF-κB activation
Resveratrol is known to have anti-inflammatory properties. However, high-dose resveratrol is required for optimal anti-inflammatory effects. HS-1793 is a derivative designed to be metabolically stable and more effective than resveratrol. We tested whether HS-1793 also has anti-inflammatory activity. HS-1793 effectively inhibited the mRNA and protein expression of lipopolysaccharide (LPS)-induced inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in macrophages. Therefore, the production of nitric oxide (NO) and prostaglandin E2 (PGE2) was significantly attenuated. In addition, HS-1793 completely suppressed the production of inflammatory cytokines enhanced by LPS treatment along with a decrease in Toll-like receptor 4 (TLR4) expression. At the same time, the expression of myeloid differentiation factor 88 (MyD88), IL-1 receptor-associated kinase 1 (IRAK1), and TNF receptor-associated factor 6 (TRAF6) signaling molecules and the nuclear translocation of nuclear factor kappa B (NF-κB)/p65 were also downregulated. We conclusively suggest that HS-1793 also exhibits anti-inflammatory properties by effectively inhibiting TLR4-mediated NF-κB activation.